-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Amgen, Raises Price Target to $340

Benzinga·06/10/2026 17:53:55
Listen to the news
Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $332 to $340.